AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the lacklustre performance of the London Stock Exchange. Chief among them is ...

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...

AstraZeneca has announced an ambitious $50 billion investment in the United States, aiming to significantly expand its ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall $50 billion investment as a response to U.S. trade policy and the political ...

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...

Drug maker AstraZeneca has announced plans to invest 50 billion dollars (£37 billion) in the US over the next five years amid ...

Gov. Youngkin announced AstraZeneca is coming to the Commonwealth. The biopharmaceutical company will help bring new jobs to ...